PHOENIX SEP Rises at Barcelona Event
PHOENIX SEP, as a single entry point to a variety of services along the nanopharmaceutical value chain, will be introduced at a special event in Barcelona.
Read more
PHOENIX SEP enters European R&I with the DESIDERATA project
PHOENIX SEP enters the European Framework Programme for Research and Innovation and supports The European Commission’s safe and sustainable by design (SSbD) framework by joining the DESIDERATA project
NaDeNo Gains Access to Nanopharmaceutical Development Services in 2nd Open Call
NaDeNo Nanoscience AS was selected to receive pro bono services to accelerate the development of their nanomedicine.
Apply for Funded Services in Nanopharmaceutical Innovation!
PHOENIX-OITB has launched the 2nd Round of its Open Call. First-stage applications are due 3 May 2024. Find out more about the funded services we offer!
Why a Single Entry Point for Nanopharmaceutical Innovation?
To introduce this new enterprise to potential customers, we sat down with PHOENIX-OITB gGmbH CEO Dr. Nazende Günday-Türeli to discuss the most frequently asked questions.
PHOENIX establishes gGmbH as one-stop-shop for nanopharmaceutical development
PHOENIX-OITB gGmbH offers an “all-in-one” Single Entry Point to users, providing manufacturing, characterization, testing and innovation-related consulting services including regulatory and business guidance to accelerate maturity of nano-pharmaceuticals and diagnostic agents.